CoCites: A citation-based method for searching scientific literature

SGLT2 Inhibitors and Their Mode of Action in Heart Failure-Has the Mystery Been Unravelled?

Steffen Pabel, Nazha Hamdani, Mark Luedde, Samuel Sossalla. Curr Heart Fail Rep 2021
Times Cited: 5

Unlocking the Secrets of Mitochondria in the Cardiovascular System: Path to a Cure in Heart Failure—A Report from the 2018 National Heart, Lung, and Blood Institute Workshop

Rong Tian, Wilson S. Colucci, Zoltan Arany, Markus M. Bachschmid, Scott W. Ballinger, Sihem Boudina, James E. Bruce, David W. Busija, Sergey Dikalov, Gerald W. Dorn, Zorina S. Galis, Roberta A. Gottlieb, Daniel P. Kelly, Richard N. Kitsis, Mark J. Kohr, Daniel Levy, E. Douglas Lewandowski, Joseph M. McClung, Daria Mochly-Rosen, Kevin D. O'Brien, Brian O'Rourke, Joon-Young Park, Peipei Ping, Michael N. Sack, Shey-Shing Sheu, Yang Shi, Sruti Shiva, Douglas C. Wallace, Robert G. Weiss, Hilary J. Vernon, Renee Wong, Lisa Schwartz Longacre. Circulation 2019
Times Cited: 44

List of shared articles

Times cited

SGLT2 inhibitors: further evidence for heart failure with preserved ejection fraction as a metabolic disease?
Justin B Echouffo-Tcheugui, Sabra C Lewsey, Robert G Weiss. J Clin Invest 2021

VDAC2 as a novel target for heart failure: Ca²⁺ at the sarcomere, mitochondria and SR.
Paul Rosenberg. Cell Calcium 2022